サンプル分類1
Cagrilintide
- 5mg*10vials USD 113.00
- 10mg*10vials USD 219.00
参考価格です。お支払いの前にコンシェルジュが金額を確認します。
4.6 / 5 · 933 件注文の送信後、コンシェルジュへ連絡するときは注文番号をお知らせください。
製品の特長
Long-acting satiety-inducing peptides; highly effective when used in combination with GLP-1.
製品紹介
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
注意事項
Reconstitution: Add 3.0 mL of bacteriostatic water → concentration ~1.67 mg/mL
Typical weekly dosage range: 0.6–4.5 mg once weekly (titrated gradually over 4–6 weeks)
Simple measurement: 1 unit = 0.01 mL ≈ 0.0167 mg (16.7 micrograms)
使い方
1. Draw 3.0 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid creating foam or vigorous agitation.
3. Gently swirl or roll the vial until the contents are completely dissolved (do not shake).
4. Label with the date and concentration; store refrigerated at 2–8°C, protected from light.
5. Use within 30 days of reconstitution; discard if the solution appears cloudy or contains particulate matter.
保存方法
Lyophilized: Store at -20°C in a dry, dark place; minimize exposure to moisture.
After reconstitution: Store refrigerated at 2–8°C; use within 30 days, and avoid freeze-thaw cycles.
レビュー
4.6 / 5
933 件
最新100件を表示しています。
-
★★★★★
VXC•••••••E7D3
オーストラリア
2026-10-26 18:42
The box was plain and undamaged. The vial matched the description. No issues on arrival.
-
★★★★★
VXC•••••••5C82
日本
2026-10-26 14:49
The handoff at the depot was slow. The inner pack was clean. I am satisfied with the item.
-
★★★★★
VX6•••••••C666
シンガポール
2026-10-26 10:56
Arrival was calm and on schedule. The contents were undamaged. Pleased with how it was sent.
-
★★★★★
VXA•••••••A540
香港
2026-10-26 07:04
Tracking was a day late. The vial was fine. The product side was fine.
-
★★★★★
VX9•••••••CE5C
フランス
2026-10-26 03:11
It arrived a couple of days after the first date. The description matched. The listing did not overstate it.
-
★★★★★
VXD•••••••EA61
英国
2026-10-25 23:18
The box arrived in good shape. The page description was accurate. Everything checked out.
-
★★★★★
VX0•••••••3B92
香港
2026-10-25 19:26
It arrived a couple of days after the first date. The batch note was readable. The delay was minor.
-
★★★★★
VX4•••••••4423
ドイツ
2026-10-25 15:33
The outer carton was solid. The vial matched the description. Everything checked out.
-
★★★★★
VX1•••••••8C1E
ドイツ
2026-10-25 11:40
The box arrived in good shape. The label matches the listing. Clear from start to finish.
-
★★★★★
VX8•••••••FBC5
カナダ
2026-10-25 07:47
The carton was dry and closed. The vial matched the description. Clear from start to finish.
購入者レビュー
注文時の注文番号と電話番号を入力してください。この商品を含む注文と両方が一致する必要があります。
ほかの掲載商品
サンプル分類1
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
参考価格USD 116.00
サンプル分類1
Retatrutide
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
参考価格USD 45.00
サンプル分類1
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
参考価格USD 40.00
サンプル分類1
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
参考価格USD 41.00